Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase

Toxicology and Industrial Health

Volumn 29, Issue 2, 2013, Pages 169-174

  Park, Hye Jeong ^a   Youn, Hyung Sun ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

cyclooxygenase 2; inducible nitric oxide synthase; inflammation; Mercury; nuclear factor B

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MERCURY;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CYTOTOXICITY; GENE CONTROL; GENE TARGETING; HOST RESISTANCE; IMMUNE SYSTEM; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; MACROPHAGES; MERCURIC CHLORIDE; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II;

EID: 84874434028     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233711427048     Document Type: Article

References (30)

1. Alvarez Y, Briones AM, Balfagon G, Alonso MJ, Salaices M (2005) Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. Journal of Hypertension 23(4): 767–777.
2. Antman EM, DeMets D, Loscalzo J (2005) Cyclooxygenase inhibition and cardiovascular risk. Circulation 112(5): 759–770.
3. Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology 14: 649–683.
4. Dieguez-Acuna FJ, Ellis ME, Kushleika J, Woods JS (2001) Mercuric ion attenuates nuclear factor-kappaB activation and DNA binding in normal rat kidney epithelial cells: implications for mercury-induced nephrotoxicity. Toxicology and Applied Pharmacology 173(3): 176–187.
5. Dieguez-Acuna FJ, Woods JS (2000) Inhibition of NF-kappaB-DNA binding by mercuric ion: utility of the non-thiol reductant, tris(2-carboxyethyl)phosphine hydrochloride (TCEP), on detection of impaired NF-kappaB-DNA binding by thiol-directed agents. Toxicology in Vitro 14(1): 7–16.
6. Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Science's STKE 2006(357): re13.
7. Hori M, Kita M, Torihashi S, Miyamoto S, Won KJ, Sato K et al. (2001) Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. American Journal of Physiology Gastrointestinal and Liver Physiology 280(5): G930–G938.
8. Jarup L (2003) Hazards of heavy metal contamination. British Medical Bulletin 68: 167–182.
9. Kim SH, Johnson VJ, Sharma RP (2002) Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide 7(1): 67–74.
10. Moncada S (1999) Nitric oxide: discovery and impact on clinical medicine. Journal of the Royal Society of Medicine 92(4): 164–169.
11. Murakami A, Ohigashi H (2007) Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. International Journal of Cancer 121(11): 2357–2363.
12. Pecanha FM, Wiggers GA, Briones AM, Perez-Giron JV, Miguel M, Garcia-Redondo AB et al. (2010) The role of cyclooxygenase (COX)-2 derived prostanoids on vasoconstrictor responses to phenylephrine is increased by exposure to low mercury concentration. Journal of Physiology and Pharmacology 61(1): 29–36.
13. Rouzer CA, Marnett LJ (2009) Cyclooxygenases: structural and functional insights. Journal of Lipid Research (suppl 50): S29–S34.
14. Salonen JT, Seppanen K, Nyyssonen K, Korpela H, Kauhanen J, Kantola M et al. (1995) Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91(3): 645–655.
15. Simmons DL, Levy DB, Yannoni Y, Erikson RL (1989) Identification of a phorbol ester-repressible v-src-inducible gene. Proceedings of the National Academy of Sciences of the United States of America 86(4): 1178–1182.
16. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK et al. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutation Research 480-481: 243–268.
17. Turini ME, DuBois RN (2002) Cyclooxygenase-2: a therapeutic target. Annual Review of Medicine 53: 35–57.
18. Vallance P (2003) Nitric oxide: therapeutic opportunities. Fundamental & Clinical Pharmacology 17: 1–10.
19. Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annual Review of Pharmacology and Toxicology 38: 97–120.
20. Weiss B, Clarkson TW, Simon W (2002) Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environmental Health Perspectives 110(suppl 5): 851–854.
21. WHO (1990) Methylmercury. Environmental Health Criteria 101. Geneva: World Health Organization.
22. WHO (1991) Inorganic Mercury. Environmental Health Criteria 118. Geneva: World Health Organization.
23. Wiggers GA, Pecanha FM, Briones AM, Perez-Giron JV, Miguel M, Vassallo DV et al. (2008) Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. American Journal of Physiology–Heart and Circulatory Physiology 295(3): H1033–H1043.
24. Wolf MB, Baynes JW (2007) Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals 20(1): 73–81.
25. Yanagisawa H, Nodera M, Wada O (1998) Inducible nitric oxide synthase expression in mercury chloride-induced acute tubular necrosis. Industrial Health 36(4): 324–330.
26. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. Journal of Immunology 175(5): 3339–3346.
27. Youn HS, Lee JY, Saitoh SI, Miyake K, Hwang DH (2006a) Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Biochemical and Biophysical Research Communications 350(4): 866–871.
28. Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ et al. (2006b) Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochemical Pharmacology 72(7): 850–859.
29. Youn HS, Saitoh SI, Miyake K, Hwang DH (2006c) Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72(1): 62–69.
30. Zalups RK (2000) Molecular interactions with mercury in the kidney. Pharmacological Reviews 52(1): 113–143.